These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22947043)

  • 21. Integrated approach to assess the domain of applicability of some commercial (Q)SAR models.
    Kulkarni SA; Zhu J
    SAR QSAR Environ Res; 2008; 19(1-2):39-54. PubMed ID: 18311633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
    Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
    J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity and validation of expert (Q)SAR systems.
    Hulzebos E; Sijm D; Traas T; Posthumus R; Maslankiewicz L
    SAR QSAR Environ Res; 2005 Aug; 16(4):385-401. PubMed ID: 16234178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-silico screening of high production volume chemicals for mutagenicity using the MCASE QSAR expert system.
    Klopman G; Chakravarti SK; Harris N; Ivanov J; Saiakhov RD
    SAR QSAR Environ Res; 2003 Apr; 14(2):165-80. PubMed ID: 12747573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the genotoxicity of secondary and aromatic amines using data subsetting to generate a model ensemble.
    Mattioni BE; Kauffman GW; Jurs PC; Custer LL; Durham SK; Pearl GM
    J Chem Inf Comput Sci; 2003; 43(3):949-63. PubMed ID: 12767154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts.
    Toropov AA; Toropova AP; Benfenati E; Salmona M
    Toxicol Mech Methods; 2018 Jun; 28(5):321-327. PubMed ID: 29281931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico prediction of chemical Ames mutagenicity.
    Xu C; Cheng F; Chen L; Du Z; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2012 Nov; 52(11):2840-7. PubMed ID: 23030379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity.
    Aptula AO; Roberts DW
    Chem Res Toxicol; 2006 Aug; 19(8):1097-105. PubMed ID: 16918251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity, carcinogenicity, and other end points.
    Benigni R; Battistelli CL; Bossa C; Colafranceschi M; Tcheremenskaia O
    Methods Mol Biol; 2013; 930():67-98. PubMed ID: 23086838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A stepwise approach for defining the applicability domain of SAR and QSAR models.
    Dimitrov S; Dimitrova G; Pavlov T; Dimitrova N; Patlewicz G; Niemela J; Mekenyan O
    J Chem Inf Model; 2005; 45(4):839-49. PubMed ID: 16045276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automatic extraction of structural alerts for predicting chromosome aberrations of organic compounds.
    Estrada E; Molina E
    J Mol Graph Model; 2006 Nov; 25(3):275-88. PubMed ID: 16487735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CORAL: building up the model for bioconcentration factor and defining it's applicability domain.
    Toropov AA; Toropova AP; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    Eur J Med Chem; 2011 Apr; 46(4):1400-3. PubMed ID: 21295893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iterative fragment selection: a group contribution approach to predicting fish biotransformation half-lives.
    Brown TN; Arnot JA; Wania F
    Environ Sci Technol; 2012 Aug; 46(15):8253-60. PubMed ID: 22779755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminating between true-positive and false-positive clinical mastitis alerts from automatic milking systems.
    Steeneveld W; van der Gaag LC; Ouweltjes W; Mollenhorst H; Hogeveen H
    J Dairy Sci; 2010 Jun; 93(6):2559-68. PubMed ID: 20494164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of structure-activity relationships to the prediction of the mutagenic activity of chemicals.
    Judson P
    Methods Mol Biol; 2012; 817():1-19. PubMed ID: 22147565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the reliability of a QSAR model's predictions.
    He L; Jurs PC
    J Mol Graph Model; 2005 Jun; 23(6):503-23. PubMed ID: 15896992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Definition of the applicability domains of knowledge-based predictive toxicology expert systems by using a structural fragment-based approach.
    Ellison CM; Enoch SJ; Cronin MT; Madden JC; Judson P
    Altern Lab Anim; 2009 Nov; 37(5):533-45. PubMed ID: 20017582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three new consensus QSAR models for the prediction of Ames genotoxicity.
    Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
    Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.